Showing results (961-970 of 9,884) with videos related to

Sort By:
Pageof 989
Antibiotics (Basel, Switzerland)|September 23, 2022
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part IIBruno Viaggi, Alice Cangialosi, Martin Langer, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Prediction of Potential Natural Antibiotics Plants Based on Jamu Formula Using Random Forest ClassifierAhmad Kamal Nasution, Sony Hartono Wijaya, Pei Gao, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of Leishmania major-Induced Leishmaniasis: In Silico and In Vitro StudiesKamal A Qureshi, Mahrukh Imtiaz, Ibrahim Al Nasr, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Novel Megaplasmid Driving NDM-1-Mediated Carbapenem Resistance in Klebsiella pneumoniae ST1588 in South AmericaMario Quezada-Aguiluz, Andrés Opazo-Capurro, Nilton Lincopan, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Impact of Skin Disinfection on Cutaneous Microbiota, before and after Peripheral Venous Catheter InsertionManon Prat, Jeremy Guenezan, Bertrand Drugeon, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo AnalysisSoraya Herrera-Espejo, Ester Del Barrio-Tofiño, Tania Cebrero-Cangueiro, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Exploring the Barriers in the Uptake of the Dutch MRSA 'Search and Destroy' Policy Using the Cascade of Care ApproachAnnette C Westgeest, Emile F Schippers, Martijn Sijbom, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide MonotherapyEunha Bae, Ye Ji Kim, Hyun Mi Kang, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Biocontrol of Candida albicans by Antagonistic Microorganisms and Bioactive CompoundsHonghua Li, Jinpeng Yang, Xinwan Zhang, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
A Riboswitch-Driven Era of New AntibacterialsNikoleta Giarimoglou, Adamantia Kouvela, Alexandros Maniatis, et al.
Pageof 989